<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>60</viewCount><searchCount>0</searchCount></scores><additional><omics_type>Unknown</omics_type><volume>3(10)</volume><submitter>Ganguly D</submitter><pubmed_abstract>Nickel-encapsulated nitrogen-doped carbon nanotubes (Ni-TiO&lt;sub>2&lt;/sub>-NCNTs) are synthesized via chemical vapor deposition by thermal decomposition of acetylene with acetonitrile vapor at 700 °C on the Ni-TiO&lt;sub>2&lt;/sub> matrix. TiO&lt;sub>2&lt;/sub> is used as a dispersant medium for Ni nanoparticles, which assists in higher CNT growth at high temperatures. A reference catalyst is made by following the similar procedure without acetonitrile vapor, which is called a Ni-TiO&lt;sub>2&lt;/sub>-CNT. Acid treatment of these two catalysts dissolved Ni on the surface of CNTs-NCNTs, producing catalysts with enhanced surface area and defects. The transmission electron microscopy-energy-dispersive X-ray spectra analysis of acid-treated version of the catalysts confirmed the presence of encapsulated Ni. Oxygen reduction reaction (ORR) activity of these catalysts was analyzed in 0.1 N KOH solution. Among these, the acid-treated Ni-TiO&lt;sub>2&lt;/sub>-NCNT exhibited highest ORR onset potential of 0.88 V versus reversible hydrogen electrode and a current density of 3.7 mA cm&lt;sup>-2&lt;/sup> at 170 μg cm&lt;sup>-2&lt;/sup> of catalyst loading. The stability of the acid-treated Ni-TiO&lt;sub>2&lt;/sub>-NCNT is proved by cyclic voltammetry and chronoamperometry measurements which are done for 800 cycles and 100 h, respectively. Primarily N doping of CNTs is the reason behind the improved ORR activity.</pubmed_abstract><journal>ACS omega</journal><pagination>13609-13620</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6644947</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Chemical Vapor Deposition-Grown Nickel-Encapsulated N-Doped Carbon Nanotubes as a Highly Active Oxygen Reduction Reaction Catalyst without Direct Metal-Nitrogen Coordination.</pubmed_title><pmcid>PMC6644947</pmcid><pubmed_authors>Ganguly D</pubmed_authors><pubmed_authors>Ramanujam K</pubmed_authors><pubmed_authors>Sundara R</pubmed_authors><view_count>60</view_count></additional><is_claimable>false</is_claimable><name>Chemical Vapor Deposition-Grown Nickel-Encapsulated N-Doped Carbon Nanotubes as a Highly Active Oxygen Reduction Reaction Catalyst without Direct Metal-Nitrogen Coordination.</name><description>Nickel-encapsulated nitrogen-doped carbon nanotubes (Ni-TiO&lt;sub>2&lt;/sub>-NCNTs) are synthesized via chemical vapor deposition by thermal decomposition of acetylene with acetonitrile vapor at 700 °C on the Ni-TiO&lt;sub>2&lt;/sub> matrix. TiO&lt;sub>2&lt;/sub> is used as a dispersant medium for Ni nanoparticles, which assists in higher CNT growth at high temperatures. A reference catalyst is made by following the similar procedure without acetonitrile vapor, which is called a Ni-TiO&lt;sub>2&lt;/sub>-CNT. Acid treatment of these two catalysts dissolved Ni on the surface of CNTs-NCNTs, producing catalysts with enhanced surface area and defects. The transmission electron microscopy-energy-dispersive X-ray spectra analysis of acid-treated version of the catalysts confirmed the presence of encapsulated Ni. Oxygen reduction reaction (ORR) activity of these catalysts was analyzed in 0.1 N KOH solution. Among these, the acid-treated Ni-TiO&lt;sub>2&lt;/sub>-NCNT exhibited highest ORR onset potential of 0.88 V versus reversible hydrogen electrode and a current density of 3.7 mA cm&lt;sup>-2&lt;/sup> at 170 μg cm&lt;sup>-2&lt;/sup> of catalyst loading. The stability of the acid-treated Ni-TiO&lt;sub>2&lt;/sub>-NCNT is proved by cyclic voltammetry and chronoamperometry measurements which are done for 800 cycles and 100 h, respectively. Primarily N doping of CNTs is the reason behind the improved ORR activity.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Oct</publication><modification>2024-02-14T20:17:44.436Z</modification><creation>2019-08-31T07:04:11Z</creation></dates><accession>S-EPMC6644947</accession><cross_references><pubmed>31458066</pubmed><doi>10.1021/acsomega.8b01565</doi></cross_references></HashMap>